The store will not work correctly when cookies are disabled.
4-((2R,6S)-3,5-Dioxo-4-aza-tricyclo[5.2.1.0*2,6*]dec-8-en-4-yl)-butyric acid
ID: ALA4858487
PubChem CID: 677385
Max Phase: Preclinical
Molecular Formula: C13H15NO4
Molecular Weight: 249.27
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(O)CCCN1C(=O)[C@@H]2[C@H](C1=O)[C@H]1C=C[C@@H]2C1
Standard InChI: InChI=1S/C13H15NO4/c15-9(16)2-1-5-14-12(17)10-7-3-4-8(6-7)11(10)13(14)18/h3-4,7-8,10-11H,1-2,5-6H2,(H,15,16)/t7-,8+,10+,11-
Standard InChI Key: WGPBWBNVJMUVEK-YDRMRZIKSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
23.6694 -24.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.3839 -24.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.0984 -24.6152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.8130 -24.2027 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.9547 -24.2027 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
22.8642 -23.3850 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.1968 -24.5412 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6446 -23.9281 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.0562 -23.2162 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.6478 -22.5077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8261 -22.5049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.4145 -23.2168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.8245 -23.9315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
21.0482 -22.9900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
22.4609 -22.4983 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
21.2274 -24.6402 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
23.4749 -22.8302 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
22.0257 -25.3483 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
26.5275 -24.6152 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
25.8130 -23.3777 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
21.6478 -21.6827 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
20.0276 -24.1450 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
1 5 1 0
5 6 1 0
9 6 1 0
8 7 1 0
7 5 1 0
8 9 1 0
13 8 1 0
9 10 1 0
10 11 1 0
11 12 2 0
13 12 1 0
13 14 1 0
10 14 1 0
9 15 1 6
8 16 1 6
6 17 2 0
7 18 2 0
4 19 2 0
4 20 1 0
10 21 1 1
13 22 1 1
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 249.27 | Molecular Weight (Monoisotopic): 249.1001 | AlogP: 0.66 | #Rotatable Bonds: 4 |
Polar Surface Area: 74.68 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.23 | CX Basic pKa: ┄ | CX LogP: 0.05 | CX LogD: -2.96 |
Aromatic Rings: ┄ | Heavy Atoms: 18 | QED Weighted: 0.59 | Np Likeness Score: -0.26 |
References
1. Richardson NL, O'Malley LJ, Weissberger D, Tumber A, Schofield CJ, Griffith R, Jones NM, Hunter L.. (2021) Discovery of neuroprotective agents that inhibit human prolyl hydroxylase PHD2., 38 [PMID:33862469] [10.1016/j.bmc.2021.116115] |